Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease-Reference-Cited by-同舟云学术

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Published:2015-05-29 Issue:3 Volume:278 Page:323-332
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Brauner S.¹,Zhou W.¹,Backlin C.²,Green T. M.³⁴,Folkersen L.¹,Ivanchenko M.¹,Löfström B.⁵,Xu-Monette Z. Y.⁶,Young K. H.⁶,Møller Pedersen L.⁴,Boe Møller M.³⁴,Sundström C.⁷,Enblad G.⁸,Baecklund E.²,Wahren-Herlenius M.¹

Affiliation:

1. Unit of Experimental Rheumatology; Department of Medicine; Karolinska University Hospital; Karolinska Institutet; Stockholm Sweden

2. Unit of Rheumatology; Department of Medical Sciences; Uppsala University; Uppsala Sweden

3. Institute of Clinical Research; University of Southern Denmark; Odense Denmark

4. Odense University Hospital; Odense Denmark

5. Rheumatology Clinic; Malar Hospital; Eskilstuna Sweden

6. Department of Hematopathology; University of Texas; MD Anderson Cancer Center; Houston TX USA

7. Department of Immunology, Genetics and Pathology; Rudbeck Laboratory; Uppsala University; Uppsala Sweden

8. Unit of Oncology; Department of Radiology, Oncology and Radiation Sciences; Uppsala University; Uppsala Sweden

Funder

Swedish Research Council

Heart-Lung Foundation

Stockholm County Council

Karolinska Institutet

Swedish Rheumatism Association

King Gustaf Vth 80-year Foundation

Torsten and Ragnar Söderberg Foundation

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12375/fullpdf

Reference36 articles.

1. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma;Fu;J Clin Oncol,2008

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

3. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

4. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis;Berglund;Mod Pathol,2005

5. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma;Dias;Nat Rev Rheumatol,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation;International Journal of Cancer;2024-02-03

2. Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course;Arthritis & Rheumatology;2023-11-27

3. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism;Cancer Cell International;2023-11-22

4. Ro52/TRIM21 – From host defense to autoimmunity;Cellular Immunology;2023-11

5. STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer;Journal of Cancer Research and Clinical Oncology;2023-08-28